LAB - STANDARD BIOTOOLS INC.

0.8973
-0.061   -6.765%

Share volume: 2,464,241
Last Updated: 03-27-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$0.96
-0.06
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 35%
Dept financing 23%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.86%
1 Month
-18.43%
3 Months
-29.90%
6 Months
-29.35%
1 Year
-21.29%
2 Year
-23.31%
Key data
Stock price
$0.90
P/E Ratio 
N/A
DAY RANGE
$0.90 - $0.96
EPS 
-$0.20
52 WEEK RANGE
$0.90 - $1.72
52 WEEK CHANGE
-$16.92
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
390.072 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,861,228
AVERAGE 30 VOLUME 
$2,590,781
Company detail
CEO: Michael Egholm
Region: US
Website: fluidigm.com
Employees: 620
IPO year: 2011
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems. The company also sells single cell microfluidics that comprise C1 systems; preparatory analytical instruments; and software solutions.

Recent news